Integrating primary care and methadone maintenance treatment: Implementation issues

被引:27
作者
Herman, M [1 ]
Gourevitch, MN [1 ]
机构
[1] MONTEFIORE MED CTR,DEPT EPIDEMIOL & SOCIAL MED,ALBERT EINSTEIN COLL MED,BRONX,NY 10467
关键词
D O I
10.1300/J069v16n01_06
中图分类号
R194 [卫生标准、卫生检查、医药管理];
学科分类号
摘要
Linking primary medical care with methadone maintenance treatment brings critical services to drug users, many with HIV/AIDS, tuberculosis and other illnesses. However, a variety of important philosophical, ethical, and systems issues may impede the process of implementing a ''linked'' service delivery model. Conflicting paradigms, such as the traditional ''doctor-patient'' relationship with its emphasis on continuity of care and the substance abuse treatment model of limit-setting and behavioral consequences, create tension in the treatment system. This article describes these tensions and uses clinical vignettes to demonstrate how to address these implementation issues. In conclusion, solutions are proposed for successfully integrating services for medically ill substance abusers.
引用
收藏
页码:91 / 102
页数:12
相关论文
共 21 条
[11]   ABSENCE OF ANTIBODY TO HUMAN IMMUNODEFICIENCY VIRUS IN LONG-TERM, SOCIALLY REHABILITATED METHADONE-MAINTENANCE PATIENTS [J].
NOVICK, DM ;
JOSEPH, H ;
CROXSON, TS ;
SALSITZ, EA ;
WANG, G ;
RICHMAN, BL ;
PORETSKY, L ;
KEEFE, JB ;
WHIMBEY, E .
ARCHIVES OF INTERNAL MEDICINE, 1990, 150 (01) :97-99
[12]   HUMAN-IMMUNODEFICIENCY-VIRUS INFECTION IN INTRAVENOUS-DRUG-USERS - A MODEL FOR PRIMARY CARE [J].
OCONNOR, PG ;
MOLDE, S ;
HENRY, S ;
SHOCKCOR, WT ;
SCHOTTENFELD, RS .
AMERICAN JOURNAL OF MEDICINE, 1992, 93 (04) :382-386
[13]   THE TRANSTHEORETICAL MODEL OF CHANGE AND HIV PREVENTION - A REVIEW [J].
PROCHASKA, JO ;
REDDING, CA ;
HARLOW, LL ;
ROSSI, JS ;
VELICER, WF .
HEALTH EDUCATION QUARTERLY, 1994, 21 (04) :471-486
[14]   IN SEARCH OF HOW PEOPLE CHANGE - APPLICATIONS TO ADDICTIVE BEHAVIORS [J].
PROCHASKA, JO ;
DICLEMENTE, CC ;
NORCROSS, JC .
AMERICAN PSYCHOLOGIST, 1992, 47 (09) :1102-1114
[15]  
SAMET JH, 1995, SUBST ABUS, V16, P131, DOI DOI 10.1080/08897079509444716
[16]  
Schlenger W, 1992, NATL EVALUATION MODE
[17]   A PROSPECTIVE-STUDY OF THE RISK OF TUBERCULOSIS AMONG INTRAVENOUS DRUG-USERS WITH HUMAN IMMUNODEFICIENCY VIRUS-INFECTION [J].
SELWYN, PA ;
HARTEL, D ;
LEWIS, VA ;
SCHOENBAUM, EE ;
VERMUND, SH ;
KLEIN, RS ;
WALKER, AT ;
FRIEDLAND, GH .
NEW ENGLAND JOURNAL OF MEDICINE, 1989, 320 (09) :545-550
[18]  
SELWYN PA, 1993, PUBLIC HEALTH REP, V108, P492
[19]   PRIMARY CARE FOR PATIENTS WITH HUMAN IMMUNODEFICIENCY VIRUS (HIV) INFECTION IN A METHADONE-MAINTENANCE TREATMENT PROGRAM [J].
SELWYN, PA ;
FEINGOLD, AR ;
IEZZA, A ;
SATYADEO, M ;
COLLEY, J ;
TORRES, R ;
SHAW, JFM .
ANNALS OF INTERNAL MEDICINE, 1989, 111 (09) :761-763
[20]   CLINICAL MANIFESTATIONS AND PREDICTORS OF DISEASE PROGRESSION IN DRUG-USERS WITH HUMAN-IMMUNODEFICIENCY-VIRUS INFECTION [J].
SELWYN, PA ;
ALCABES, P ;
HARTEL, D ;
BUONO, D ;
SCHOENBAUM, EE ;
KLEIN, RS ;
DAVENNY, K ;
FRIEDLAND, GH .
NEW ENGLAND JOURNAL OF MEDICINE, 1992, 327 (24) :1697-1703